Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Pacira BioSciences revenue
Pacira BioSciences's revenue is $675.0 million.
What is Pacira BioSciences's revenue?
- Pacira BioSciences's revenue growth from 2009 to 2023 is 4,398.05%.
- Pacira BioSciences has 750 employees, and the revenue per employee ratio is $899,970.
- Pacira BioSciences's peak quarterly revenue was $181.2M in 2023(q4).
- Pacira BioSciences annual revenue for 2022 was 666.8M, 23.14% growth from 2021.
- Pacira BioSciences annual revenue for 2023 was 675.0M, 1.22% growth from 2022.
- Pacira BioSciences peak revenue was $675.0M in 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Pacira BioSciences historical revenue
Pacira BioSciences's peak revenue was $675.0M in 2023. The peak quarterly revenue was $181.2M in 2023(q4).
Pacira BioSciences's revenue increased from $15.0m in 2009 to $675.0M currently. That's a 4,398.05% change in annual revenue.
Pacira BioSciences annual revenue
Pacira BioSciences annual revenue over time
| Fiscal year / year | Pacira BioSciences revenue |
|---|---|
| 2009 | $15.0M |
| 2010 | $14.6M |
| 2011 | $15.7M |
| 2012 | $39.1M |
| 2013 | $85.6M |
| 2014 | $197.7M |
| 2015 | $249.0M |
| 2016 | $276.4M |
| 2017 | $286.6M |
| 2018 | $337.3M |
| 2019 | $421.0M |
| 2020 | $429.6M |
| 2021 | $541.5M |
| 2022 | $666.8M |
| 2023 | $675.0M |
Rate Pacira BioSciences' financial transparency
Pacira BioSciences annual growth
Pacira BioSciences saw the greatest revenue growth in 2012, when revenue increased by 149.12%.
Pacira BioSciences had the lowest revenue growth in 2010, when revenue changed by -2.96%.
Pacira BioSciences annual growth rate over time
| Year | Pacira BioSciences growth |
|---|---|
| 2010 | -3%↓ |
| 2011 | 8%↑ |
| 2012 | 149%↑ |
| 2013 | 119%↑ |
| 2014 | 131%↑ |
| 2015 | 26%↑ |
| 2016 | 11%↑ |
| 2017 | 4%↑ |
| 2018 | 18%↑ |
| 2019 | 25%↑ |
| 2020 | 2%↑ |
| 2021 | 26%↑ |
| 2022 | 23%↑ |
| 2023 | 1%↑ |
Pacira BioSciences quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Pacira BioSciences quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2010 | - | - | - | $2.2M |
| 2011 | $3.9M | $3.6M | $4.0M | $4.2M |
| 2012 | $7.8M | $12.3M | $8.5M | $10.5M |
| 2013 | $11.6M | $17.1M | $23.3M | $33.6M |
| 2014 | $36.7M | $47.2M | $52.0M | $61.8M |
| 2015 | $58.3M | $59.1M | $62.2M | $69.3M |
| 2016 | $65.5M | $69.6M | $68.4M | $72.9M |
| 2017 | $69.3M | $70.9M | $67.3M | $79.1M |
| 2018 | $74.6M | $84.1M | $83.4M | $95.1M |
| 2019 | $91.3M | $102.6M | $104.7M | $122.4M |
| 2020 | $105.7M | $75.5M | $117.5M | $131.0M |
| 2021 | $119.0M | $135.6M | $127.7M | $159.2M |
| 2022 | $158.0M | $169.4M | $167.5M | $172.0M |
| 2023 | $160.3M | $169.5M | $163.9M | $181.2M |
| 2024 | $167.1M | $178.0M | $168.6M | - |
Pacira BioSciences jobs nearby
Do you work at Pacira BioSciences?
Is Pacira BioSciences transparent about its revenue structure?
Pacira BioSciences financial information
| CEO | David M. Stack |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 750 |
| Date Founded | 2006 |
| Headquarters | Parsippany-Troy Hills, New Jersey |
| Number of Locations | 5 |
| Revenue | $675.0M |
| Net Income | $15,909,000 |
| Gross Proft | $490.3M (2023) |
| EBITDA | $127.9M (2023) |
| PE Ratio | 38.47 |
| Tax Rate | 0.3% |
| Market Capitalization | $1.6B |
| Total Assets | $1,681,200,000 |
| Ticker | PCRX |
Pacira BioSciences jobs you might like
Pacira BioSciences financing
Pacira BioSciences received early financing of $85.0M on 2008-11-17.
| Series | Round size | Date |
|---|---|---|
| Series A | $85M | 11/2008 |
| Post Ipo Debt | $27.5M | 05/2012 |
Pacira BioSciences investors
| Investors | Security type |
|---|---|
| HBM Healthcare Investments AG | Series A |
| Sanderling Ventures | Series A |
| MPM Capital | Series A |
| OrbiMed Advisors | Series A |
| Oxford Finance LLC | Post Ipo Debt |
Pacira BioSciences competitors
Pacira BioSciences's top competitor, Merck, earned an annual revenue of $64.2B.
Pacira BioSciences's smallest competitor is AcelRx Pharmaceuticals with revenue of $651.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Achillion Pharmaceuticals | $75,385 | $15.0M | 56 | - |
| Chiasma | $65,048 | $1.1M | 18 | - |
| Merck | $90,328 | $64.2B | 74,000 | 1,531 |
| AcelRx Pharmaceuticals | $79,060 | $651,000 | 54 | - |
| PerSeptive Biosystems, Inc | $74,665 | - | 605 | - |
| ALZA Corporation | $59,528 | $200.0M | 10,000 | - |
| Nektar Therapeutics | $83,561 | $98.4M | 718 | - |
| Catalent Pharma Solutions | $61,108 | $4.4B | 14,000 | 330 |
| Ivax Research | $58,757 | $2.2B | 10,100 | - |
| Watson Pharma Pvt Ltd | $79,372 | $5.9B | 21,600 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Pacira BioSciences highest paying jobs
Zippia gives an in-depth look into the details of Pacira BioSciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Pacira BioSciences. The employee data is based on information from people who have self-reported their past or current employments at Pacira BioSciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Pacira BioSciences. The data presented on this page does not represent the view of Pacira BioSciences and its employees or that of Zippia.
Pacira BioSciences may also be known as or be related to Pacira BioSciences, Pacira BioSciences Inc, Pacira Pharmaceuticals, Pacira Pharmaceuticals Inc and Pacira Pharmaceuticals, Inc.